EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Panomics in metabolic dysfunction-associated steatotic liver disease: unravelling the drivers of disease heterogeneity

Carlos José Pirola, Silvia Sookoian

Clinical and Molecular Hepatology · 01.01.2026 · 32 (1) · 156-169

DOI: 10.3350/cmh.2025.0960 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical and Molecular Hepatology, erschienen am 01.01.2026. Verfasst von Carlos José Pirola und 1 weiteren Autor:innen. Beteiligte Einrichtung: Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Buenos Aires, Argentina. Hauptthemen laut MEDLINE: Fatty Liver. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 92 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The knowledge accumulated over the past two decades has revealed that the natural history of metabolic dysfunction-associated steatotic liver disease (MASLD) and the drivers of the disease severity are not only complex but also exhibit variation among patients. This intricate clinical scenario entails major therapeutic and management implications. In this review, we provide a comprehensive examination of recent advancements in our understanding of MASLD heterogeneity, drawing insights from multiomics and panomics studies. The discussion herein explores the instrumental role of panomics in MASLD research, elucidating the potential for the identification of molecular subtypes that exhibit divergent survival outcomes or heterogeneous responses to various treatments. Furthermore, we provide insights into the challenges in addressing disease heterogeneity and potential solutions. Finally, the most advanced technological advancements and prospective research directions in the domain of MASLD research are delineated, with the objective of facilitating the implementation of personalized diagnosis and interventions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fatty LiverHumansMultiomics

Stichwörter der Autor:innen

GenomicsMASHMetabolomicsOMICSProteomics

Autor:innen und Institutionen

  • Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Buenos Aires, Argentina.
  • Systems Biology of Complex Diseases, Translational Research in Health Center (CENITRES), Maimónides University, Buenos Aires, Argentina.
  • Clinical and Molecular Hepatology, Translational Research in Health Center (CENITRES), Maimónides University, Buenos Aires, Argentina.

Zitieren

APA

Pirola, C. J., & Sookoian, S. (2026). Panomics in metabolic dysfunction-associated steatotic liver disease: unravelling the drivers of disease heterogeneity. Clinical and Molecular Hepatology, 32(1), 156-169. https://doi.org/10.3350/cmh.2025.0960

Vancouver

Pirola CJ, Sookoian S. Panomics in metabolic dysfunction-associated steatotic liver disease: unravelling the drivers of disease heterogeneity. Clinical and Molecular Hepatology. 2026;32(1):156-169. doi:10.3350/cmh.2025.0960

BibTeX
@article{Pirola2026,
  author = {Pirola, Carlos José and Sookoian, Silvia},
  title = {Panomics in metabolic dysfunction-associated steatotic liver disease: unravelling the drivers of disease heterogeneity},
  journal = {Clinical and Molecular Hepatology},
  year = {2026},
  volume = {32},
  number = {1},
  pages = {156--169},
  doi = {10.3350/cmh.2025.0960}
}
Kostenlos starten →